Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins

Diabetes

Volumn 48, Issue 3, 1999, Pages 616-622

  Olsson, Urban ^a,b   Bondjers, Göran ^a   Camejo, Germán ^a,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF BORÅS   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DARGLITAZONE; DECORIN; FATTY ACID; GLYCOSAMINOGLYCAN; PROTEOGLYCAN; THIAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTERY MUSCLE; ARTICLE; ATHEROGENESIS; CELL PROLIFERATION; CELL STRUCTURE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033048179     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.3.616     Document Type: Article

References (51)

1. Tamsma JT, van den Born J, Brujin JA, Assmann KJ, Weening JJ, Berden JH, Wieslander J, Schrama E, Hermans J, Veerkamp JH: Expression of glomerular extracellular matrix components in human nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37:313-320, 1994
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
3. Wasty F, Alavi MZ, Moore S: Distibution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia 36:316-322, 1993
4. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
5. Roden M, Price TB, Petsehgin G, Falk Petersen K, Rothman DL, Cline GW, Shulman GI: Mechanism of free fally acid-induced insulin resistance in humans. J Clin Invest 97:2859-2865, 1996
6. Hawkins M, Barzilai N, Hu M, Chen W, Rossetti L: Role of the glucosamine pathway in fat-induced insulin resistance. J Clin Invest 99:2173-2182, 1997
7. Williams KJ, Tabas I: The response-to-retention hypothesis in early atherogenesis. Arterioscler Thromb Vasc Biol 15:551-561, 1995
8. Hurt-Camejo E, Olsson U, Wiklund O, Bondjers G, Camejo G: Cellular consequences of the association of apoB lipoproteins with proteoglycans: potential contribution to atherogenesis. Arterioscler Thromb Vasc Biol 17:1011-1017, 1997
9. Olsson U, Camejo G, Hurt-Camejo E, Elfsberg K, Wiklund O, Bondjers G: Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the apoB/E receptor. Arterioscler Thromb Vasc Biol 17:149-155, 1997
10. Olson U, Camejo G, Olofsson S-O, Bondjers G: Molecular parameters that control the association of low-density lipoprotein apoB-100 with chondroitin sulphate. Biochem Biophys Acta 1097:37-44, 1991
11. Olson U, Camejo G, Bondjers G: Binding of synthetic apolipoprotein B-100 analogues to chondroitin-6-sulfate: effects of the lipid environment. Biochemistry 32:1858-1865, 1993
12. Wight TN: The vascular extracellular matrix. In Atherosclerosis and Coronary Artery Discease I. Fuster V, Ross R, Topol E, Eds. Philadelphia, PA, Lippincott-Raven, 1996, p. 421-440
13. Ramasamy S, Boissenault GA, Lipke DW, Hennig B: Proteoglycans and endothelial barrier function: effect of linoleic acid exposure to porcine pulmonary artery endothelial cells. Atherosclerosis 103:279-290, 1993
14. Hennig B, Lipke DW, Biossonneault GA, Ramasamy S: Role of fatty acids and eicosaniods in modulating proteoglycan metabolism in endothelial cells. Prostaglandins Leukot Essent Fatty Acids 53:315-324, 1995
15. Hurt-Camejo E, Camejo G, Rosengren B, López F, Wiklund O, Bondjers G: Differential uptake of prolooglycan-selected subfractions of low-density lipoprotein by human macrophages. J Lipid Res 31:1387-1398, 1990
16. Fager G, Hansson G, Ottoson P, Dahlöf B, Bondjers G: Human arterial smooth muscle cells in culture. Exp Cell Res 176:319-335, 1988
17. Connor WE: The decisive influence of diet on the progression and reversibility of coronary heart disease. Am J Clin Nutr 64:253-254, 1996
18. Spector AA: Stracture and lipid binding properties of serum albumin. Methods Enzymol 128:320-339, 1986
19. Esterbauer H, Gebicki J, Puhl H, Jürgens G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13:341-390, 1992
20. de Herreros G, Birnbaum MJ: The acquisition of increased insulin-responsive hexose transport in 3T3-L1 adipocytes correlates with expression of a novel transporter gene. J Biol Chem 264:19994-19999, 1989
21. Wiesner RJ, Rüegg C, Morano I: Counting target molecules by exponential polymerase chain reaction: copy number of mitochondrial DNA in rat tissues. Biochem Biophys Res Commun 183-553-559, 1992
22. Wolf YG, Rasmussen LM, Ruoslahti E: Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J Clin Invest 93:1172-1178, 1994
23. + mRNA isoforms: mulecular markers for hepatocellular carcinoma. Int J Cancer 56:820-825, 1994
24. Friedman SL, Rockey DC, McGuire RF, Maher JJ, Boyles JK, Yamasaki G: Isolated hepathic lipocytes and kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology 15:234-243, 1992
25. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA: The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 271:10079-10086, 1996
26. Gallo RL, Ono M, Posvic T, Page C, Eriksson E, Klagsburn M, Bernfield M: Syndecans, cell surface heparan sulfate proteoglycans, are induced by a prolinerich antimicrobial peptide from wounds. Proc Natl Acad Sci U S A 91:11035-11039, 1994
27. Hurt-Camejo E, Rosengren B, Camejo G, Sartipy P, Fager G, Bondjers G: Interferon gamma binds to extracellular matrix chondroitin-sulfate proteoglycans, thus enhancing its cellular respond. Arterioscler Thromb Vasc Biol 15:1456-1465, 1995
28. Sartipy P, Johansen B, Camejo G, Rosengren B, Bondjers G, Hurt-Camejo E: Binding of human phospholipase A2 type II to proteoglycans: diffrential effect of glycosaminoglycans on enzyme activity. J Biol Chem 271: 26307-26314, 1996
29. Hurt-Camejo E, Camejo G, Sartipy P: Measurement of proteoglycan-lipoprotein interactions by gel mobility shift assay. In Methods in Molecular Biology, Theory and Practice. Ordováz J, Ed. Totowa NJ, Human Press, 1998, p. 267-279
30. Chen Y-D, Reaven G: Insulin resistance and atherosclerosis. Diabetes Rev 5:331-342, 1998
31. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M: Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation 91:831-837, 1995
32. Steele RH, Wagner WD, Rowe HA, Edwards IJ: Artery wall-derived proteoglycan-plasma lipoprotein interaction: lipoprotein binding properties of extracted proteoglycans. Atherosclerosis 65:51-62, 1987
33. Camejo G, Fager G, Rosengren B, Hurt-Camejo E, Bondjers G: Binding of low-density lipoproteins by proteogylcans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem 268:14131-14137, 1993
34. Cardoso LE, Mourao PA: Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb 14:115-124, 1994
35. Edwards IJ, Xu H, Obunike JC, Goldberg IJ, Wagner WD: Differentiated macrophages synthesize a heparan sulfate proteoglycan and an oversulfated chondroitin sulfate proteoglycan that bind lipoprotein lipase. Arterioscler Thromb Vasc Biol 15:400-409, 1995
36. Smith EB, Staples EM: Distribution of plasma proteins across the human aortic wall: barrier functions of endothelium and internal elastic lamina. Atherosclerosis 37:579-590, 1980
37. 14-labeled unesterified fatty acids in normal human subjects. J Clin Invest 37:1504-1515, 1958
38. Gilbert RE, Cox A, Dziadek M, Cooper ME, Jerums G: Extracellular matrix and its interactions in the diabetic kidney: a molecular biological approach. J Diabetes Complications 9:252-254, 1995
39. Shami SK, Chittenden SJ: Microangiopathy in diabetes mellitos. II. Features, complications, and investigation. Diabetes Res 17:157-168, 1991
40. Klein DJ, Cohen RM, Rymaszewski Z: Proteoglycan synthesis by bovine myocardial endothelial cells is increased by long-term exposure to high concentrations of glucose. J Cell Physiol 165:493-502, 1995
41. Hennig B, Shasby DM, Fulton AB, Spector AA: Exposure to free fatty acid increases the transfer of albumin across cultured endothelial monolayers. Arteriosclerosis 4:489-497, 1984
42. Hennig B, Shasby DM, Spector AA: Exposure to fatty acid increases human low-density lipoprotein transfer across cultured endothelial monolayers. Circ Res 57:776-780, 1985
43. Hennig B, Watkins BA: Linoleic acid and linolenic acid: effect on permeability properties of cultured endothelial cell monolayers. Am J Clin Nutr 49:301-305, 1989
44. Cizmeci-Smith G, Langan E, Youkey J, Showalter LJ, Carey DJ: Syndecan 4 is a primary-response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17:172-180, 1997
45. Woods A, Couchman JR: Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Mol Biol Cell 5:183-192, 1994
46. Niot I, Poirier H, Besnard P: Regulation of gene expression by fatty acids: special reference to fatty acid binding protein (FABP). Biochimie 79:129-133, 1997
47. Amri EZ, Teboul L, Vannier C, Grimaldi PA: Fatty acids regulate the expression of lipoprotein lipase gene and activity in preadipose and adipose cells. Biochem J 314:541-546, 1996
48. Sfeir Z, Ibrahimi A, Amri E, Grimaldi P, Abumrad N: Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport. Prostaglandins Leukot Essent Fatty Acids 57:17-21, 1997
49. Cheema SK, Clandinin MT: Diet fat alters expression of genes for enzymes of lipogenesis in lean and obese mice. Biochim Biophys Acta 1299:284-288, 1996
50. Schoonjans K, Martin G, Staels B, Auwerx J: Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 8:159-166, 1997
51. Iijima K, Yoshizumi M, Ako J, Eto M, Kim S, Hashimoto M, Sugimoto N, Liang Y-Q, Sudoh N, Toba K, Ouchi Y: Expression of peroxisome proliferator-activated receptor gamma (PPARγ) in rat aortic smooth muscle cells. Biochem Biophys Res Commun 247:353-356, 1998